Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 05, 2019
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
Journal: JAMA oncology
Published: May 01, 2018
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 16, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.
Journal: JAMA oncology
Published: February 15, 2017
Current imaging and therapy of malignant soft tissue tumors and tumor-like lesions.
Journal: Seminars in musculoskeletal radiology
Published: May 16, 2013
Showing 1-7 of 7
Last Updated: 09/26/2026